Template:21-hydroxylase deficiency: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) m (Usama Talib moved page Template:21-Hydroxylase Deficiency to Template:21-hydroxylase deficiency without leaving a redirect) |
No edit summary |
||
(5 intermediate revisions by 2 users not shown) | |||
Line 3: | Line 3: | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
'''21- | '''[[Congenital adrenal hyperplasia|Congenital adrenal hyperplasia main page]]''' | ||
''' | |||
|- bgcolor="LightGrey" | |||
! | |||
|- | |||
| colspan="1" style="text-align:center; background:DarkGray" | | |||
'''21-hydroxylase deficiency Microchapters | |||
''' | ''' | ||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
Line 10: | Line 18: | ||
|- bgcolor="LightCoral" | |- bgcolor="LightCoral" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency|Home]] | ||
|- | |- | ||
! | ! | ||
Line 16: | Line 24: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency (patient information)|Patient Information]] | ||
|- | |- | ||
! | ! | ||
Line 22: | Line 30: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency overview|Overview]] | ||
|- | |- | ||
! | ! | ||
Line 28: | Line 36: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency historical perspective|Historical Perspective]] | ||
|- | |- | ||
! | ! | ||
Line 34: | Line 42: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency classification|Classification]] | ||
|- | |- | ||
! | ! | ||
Line 40: | Line 48: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency pathophysiology|Pathophysiology]] | ||
|- | |- | ||
! | ! | ||
Line 46: | Line 54: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency causes|Causes]] | ||
|- | |- | ||
! | ! | ||
Line 52: | Line 60: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency differential diagnosis|Differentiating 21-Hydroxylase Deficiency from other Diseases]] | ||
|- | |- | ||
! | ! | ||
Line 58: | Line 66: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
Line 64: | Line 72: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
Line 70: | Line 78: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency screening|Screening]] | ||
|- | |- | ||
! | ! | ||
Line 76: | Line 84: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency natural history, complications and prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
Line 88: | Line 96: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency history and symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
Line 94: | Line 102: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency physical examination|Physical Examination]] | ||
|- | |- | ||
! | ! | ||
Line 100: | Line 108: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency laboratory findings|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
Line 106: | Line 114: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency x ray|X Ray]] | ||
|- | |- | ||
! | ! | ||
Line 112: | Line 120: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency CT|CT]] | ||
|- | |- | ||
! | ! | ||
Line 118: | Line 126: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency MRI|MRI]] | ||
|- | |- | ||
! | ! | ||
Line 124: | Line 132: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency ultrasound|Ultrasound]] | ||
|- | |- | ||
! | ! | ||
Line 130: | Line 138: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency other imaging findings|Other Imaging Findings]] | ||
|- | |- | ||
! | ! | ||
Line 136: | Line 144: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency other diagnostic studies|Other Diagnostic Studies]] | ||
|- | |- | ||
! | ! | ||
Line 154: | Line 156: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency medical therapy|Medical Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 166: | Line 162: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency surgery|Surgery]] | ||
|- | |- | ||
! | ! | ||
Line 172: | Line 168: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency primary prevention|Primary Prevention]] | ||
|- | |- | ||
! | ! | ||
Line 178: | Line 174: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency secondary prevention|Secondary Prevention]] | ||
|- | |- | ||
! | ! | ||
Line 184: | Line 180: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 190: | Line 186: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiency future or investigational therapies|Future or Investigational Therapies]] | ||
|- | |- | ||
! | ! | ||
Line 202: | Line 198: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[21- | [[21-hydroxylase deficiencycase study one|Case #1]] | ||
|- | |- | ||
! | ! |
Latest revision as of 16:18, 24 September 2017
21-hydroxylase deficiency Microchapters |
Differentiating 21-Hydroxylase Deficiency from other Diseases |
Diagnosis |
Treatment |
Case Studies |
21-hydroxylase deficiency On the Web |
American Roentgen Ray Society Images of 21-hydroxylase deficiency |
Risk calculators and risk factors for 21-hydroxylase deficiency |